Evaluation of Patient-Reported Outcomes and Quality of Life with the I-neb AAD System in Patients with Chronic Obstructive Pulmonary Disease
Author:
Affiliation:
1. Glenfield Hospital, Leicester, United Kingdom.
2. Philips Respironics, Respiratory Drug Delivery, Parsippany, New Jersey.
3. Philips Respironics, Respiratory Drug Delivery (UK) Ltd, Chichester, United Kingdom.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine
Link
http://www.liebertpub.com/doi/pdf/10.1089/jamp.2009.0767
Reference18 articles.
1. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
2. Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines
3. Patient preference for and satisfaction with inhaler devices
4. The science of nebulised drug delivery
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pilot Study to Investigate the Benefits of the InnoSpire Go Mesh Nebulizer Compared to Jet Nebulizers in the Treatment of Stable COPD;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2022-08-01
2. Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trial;Respiratory Medicine;2020-09
3. Recent advances in aerosol devices for the delivery of inhaled medications;Expert Opinion on Drug Delivery;2020-01-20
4. Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD;International Journal of Chronic Obstructive Pulmonary Disease;2019-12
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
5. Satisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety Study;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2019-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3